Opdivo®

DRUG2 trials

Sponsors

Shandong Boan Biotechnology Co., Ltd, Ono Pharmaceutical Co. Ltd

Conditions

Colorectal CancerEsophageal Squamous Cell Carcinoma

Phase 2

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

RecruitingNCT06948448

Ono Pharmaceutical Co. LtdColorectal Cancer

Start: 2025-11-18End: 2028-10-01Target: 144Updated: 2026-03-27

Phase 3

A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively With Chemotherapy in Advanced or Metastatic Esophageal Squamous Cell Carcinoma

RecruitingNCT06022861

Shandong Boan Biotechnology Co., LtdEsophageal Squamous Cell Carcinoma

Start: 2023-10-12End: 2026-12-31Target: 510Updated: 2024-09-19